Targeting the Retinoic Acid Pathway to Eradicate Cancer Stem Cells
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24032373 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Geoffrey Brown. Beteiligte Einrichtung: School of Biomedical Sciences, Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingha…. Hauptthemen laut MEDLINE: Liver Neoplasms, Ovarian Neoplasms. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FP7 EU Framework, European Union’s Seventh Framework Programme.
Abstract (Originalsprache)
All-trans retinoic acid is a morphogen during embryogenesis and a teratogen. Cancer is an error of development, and the retinoic acid receptors (RAR) for all-trans retinoic acid play a role in cancer. Expression of the cytosolic aldehyde dehydrogenases, which mediate the last step to the synthesis of all-trans retinoic acid, is deregulated in various human cancers. Inhibiting these enzymes using a variety of agents reduced the proliferation of lung cancer cells, reduced the proliferation and induced apoptosis of ovarian, prostate, squamous, and uterine cancer cells, and sensitised breast, colorectal and ovarian cancer cells to chemotherapeutic agents. RARγ is an oncogene within some cases of AML, cholangiocarcinoma, colorectal cancer, clear cell renal cell carcinoma, hepatocellular carcinoma, pancreatic ductal adenocarcinoma, prostate cancer, and ovarian cancer. Pan-RAR and RARγ antagonist inhibition of the action of RARγ led to necroptosis of human prostate and pediatric brain tumour cancer stem cells. Treatment of hepatocellular carcinoma cells with the flavenoid acacetin, which interferes with the action of RARγ, decreased cell growth and induced apoptosis. Targeting the retinoic acid pathway is promising regarding the development of new drugs to eradicate cancer stem cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Biomedical Sciences, Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
ORCID-Profile: Geoffrey Brown
Förderung
- FP7 EU Framework
- European Union’s Seventh Framework Programme
Zitieren
APA
Brown, G. (2023). Targeting the Retinoic Acid Pathway to Eradicate Cancer Stem Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032373
Vancouver
Brown G. Targeting the Retinoic Acid Pathway to Eradicate Cancer Stem Cells. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032373
BibTeX
@article{Brown2023,
author = {Brown, Geoffrey},
title = {Targeting the Retinoic Acid Pathway to Eradicate Cancer Stem Cells},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24032373}
}
EUVIMED